News

“The co-founders took a chance on the business idea for Q1 Scientific because outsourcing storage wasn’t really a thing at ...
Deep Digital Solutions Group is an emerging leader in digitalisation and data services for the life sciences sector ...
A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S.
Pharmaceutical companies in China are reportedly importing some drugs without tariffs, a sign of potential flexibility amid ...
Industries that range from pharmaceuticals to tech, and even fashion, have signaled they could build more capacity in the U.S ...
SHANGHAI (Reuters) -The Beijing-based American Chamber of Commerce said on Friday that companies in the pharmaceutical sector ...
Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on ...
Unfortunately, the same cannot be said for Europe. While it has been home to some of the most important biopharmaceutical companies in the world – many of which have consistently delivered ...
Some tariffs remain in place against key U.S. trading partners, but others have been postponed to give nations time to ...
Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...
Ahead of its scheduled opening later this year, the massive Fujifilm Diosynth Biotechnologies manufacturing plant in Holly Springs has added a new customer in a lucrative deal. On Tuesday, Fujifilm ...
A growing number of pharmaceutical companies are sharing plans to ramp up domestic manufacturing capacity amid recent tariffs imposed by the Trump administration. Here are five things to know: ...